Tag: active_pharmaceutical_ingredients
-
Pentagon's Office of Strategic Capital Signs $80 Million Conditional Loan with Antheia to Onshore Drug Production
The Department of War's Office of Strategic Capital has signed an $80 million conditional loan commitment with Antheia, Inc. to scale domestic production of key starting materials and active pharmaceutical ingredients.
BusinessHealthPolitics and GovernmentFederal GovernmentEconomyTradeMedical ScienceWhite House Office of Strategic CapitalAntheia, Inc.Department of Waractive pharmaceutical ingredientsbiomanufacturingExecutive Order 13944pharmaceutical supply chainU.S. Department of War